Report cover image

Global Veterinary Renal Disease Market Growth, Size, Trends Analysis- By Product Type, By Animal Type, By Route of Administration, By Indication, By Distribution Channel - Regional Outlook, Competitive Strategies and Segment Forecast to 2034

Publisher SPER Market Research Pvt. Ltd.
Published May 28, 2025
Length 256 Pages
SKU # SPER20187052

Description

Veterinary Renal Disease Market Introduction and Overview

According to SPER market research, ‘Global Veterinary Renal Disease Market Size- Global Veterinary Renal Disease Market – Regional Outlook, Competitive Strategies and Segment Forecast to 2034’ state that the Global Veterinary Renal Disease Market is predicted to reach 33.11 Billion by 2034 with a CAGR 6.97%.

Veterinary renal disease encompasses a variety of conditions that affect the kidneys of animals, particularly companion animals like dogs and cats, as well as livestock. These conditions can be either acute or chronic, with chronic kidney disease (CKD) being one of the most prevalent and progressive, especially in older pets.

Restraints:

The veterinary renal disease market faces multiple challenges, including the high cost of treatment and the complexity of managing chronic kidney disease (CKD) in animals. Many renal conditions require ongoing care, which can be financially taxing for both pet owners and veterinary clinics. Furthermore, the lack of awareness about early signs of kidney disease among pet owners often leads to delayed diagnoses, making treatment less effective.

Scope of the report:

Report Metric Details
Market size available for years 2021-2034
Base year considered 2024
Forecast period 2025-2034

Segments covered

By Product Type, By Animal Type, By Route of Administration, By Indication, By Distribution Channel

Regions covered

North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa

Companies Covered

Mars, Incorporated, Nestle Purina PetCare, Zoetis Inc., Merck & Co., Inc. (Merck Animal Health), Elanco Animal Health, IDEXX Laboratories, Inc., Boehringer Ingelheim Animal Health, Ceva Sante Animale, Dechra Pharmaceuticals PLC, General Mills (Blue Buffalo Pet Products).

Global Veterinary Renal Disease Market Segmentation:

By Product Type: Based on the Product Type, Global Veterinary Renal Disease Market is segmented as; Diagnosis, Treatment.

By Animal Type: Based on the Animal Type, Global Veterinary Renal Disease Market is segmented as; Canine, Feline, Bovine, Equine, Others.

By Indication: Based on the Indication, Global Veterinary Renal Disease Market is segmented as; Renal Failure, Chronic Kidney Disease (CKD), Renal Cystitis, Kidney Stones, Neprhritis, Others.

By Route of Administration: Based on the Route of Administration, Global Veterinary Renal Disease Market is segmented as; Oral, Injectable.

By Distribution Channel:

Based on the Distribution Channel, Global Veterinary Renal Disease Market is segmented as; Veterinary Hospitals & Clinics, Pet Specialty Stores, E-Commerce, Others.

By Region:

This research also includes data for North America, Latin America, Asia-Pacific, Europe and Middle East & Africa.

Table of Contents

256 Pages
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPERs internal database
2.1.4. Premium insight from KOLs
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTERs Five Forces
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Global Veterinary Renal Disease Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Veterinary Renal Disease Market
7. Global Veterinary Renal Disease Market, By Product Type, (USD Million) 2021-2034
7.1. Diagnosis
7.1.1. Test Kits & Consumables
7.1.2. Instruments
7.2. Treatment
7.2.1. Drugs
7.2.2. Therapeutic Food Supplements
7.2.3. Ringer Lactate Solution
8. Global Veterinary Renal Disease Market, By Animal Type, (USD Million) 2021-2034
8.1. Canine
8.2. Feline
8.3. Bovine
8.4. Equine
8.5. Others
9. Global Veterinary Renal Disease Market, By Route of Administration, (USD Million) 2021-2034
9.1. Oral
9.2. Injectable
10. Global Veterinary Renal Disease Market, By Indication, (USD Million) 2021-2034
10.1. Renal Failure
10.2. Chronic Kidney Disease (CKD)
10.3. Renal Cystitis
10.4. Kidney Stones
10.5. Neprhritis
10.6. Others
11. Global Veterinary Renal Disease Market, By Distribution Channel, (USD Million) 2021-2034
11.1. Veterinary Hospitals & Clinics
11.2. Pet Specialty Stores
11.3. E-Commerce
11.4. Others
12. Global Veterinary Renal Disease Market, (USD Million) 2021-2034
12.1. Global Veterinary Renal Disease Market Size and Market Share
13. Global Veterinary Renal Disease Market, By Region, 2021-2034 (USD Million)
13.1. Asia-Pacific
13.1.1. Australia
13.1.2. China
13.1.3. India
13.1.4. Japan
13.1.5. South Korea
13.1.6. Rest of Asia-Pacific
13.2. Europe
13.2.1. France
13.2.2. Germany
13.2.3. Italy
13.2.4. Spain
13.2.5. United Kingdom
13.2.6. Rest of Europe
13.3. Middle East and Africa
13.3.1. Kingdom of Saudi Arabia
13.3.2. United Arab Emirates
13.3.3. Qatar
13.3.4. South Africa
13.3.5. Egypt
13.3.6. Morocco
13.3.7. Nigeria
13.3.8. Rest of Middle-East and Africa
13.4. North America
13.4.1. Canada
13.4.2. Mexico
13.4.3. United States
13.5. Latin America
13.5.1. Argentina
13.5.2. Brazil
13.5.3. Rest of Latin America
14. Company Profile
14.1. Mars, Incorporated
14.1.1. Company details
14.1.2. Financial outlook
14.1.3. Product summary
14.1.4. Recent developments
14.2. Nestle Purina PetCare
14.2.1. Company details
14.2.2. Financial outlook
14.2.3. Product summary
14.2.4. Recent developments
14.3. Zoetis Inc.
14.3.1. Company details
14.3.2. Financial outlook
14.3.3. Product summary
14.3.4. Recent developments
14.4. Merck & Co., Inc. (Merck Animal Health)
14.4.1. Company details
14.4.2. Financial outlook
14.4.3. Product summary
14.4.4. Recent developments
14.5. Elanco Animal Health
14.5.1. Company details
14.5.2. Financial outlook
14.5.3. Product summary
14.5.4. Recent developments
14.6. IDEXX Laboratories, Inc.
14.6.1. Company details
14.6.2. Financial outlook
14.6.3. Product summary
14.6.4. Recent developments
14.7. Boehringer Ingelheim Animal Health
14.7.1. Company details
14.7.2. Financial outlook
14.7.3. Product summary
14.7.4. Recent developments
14.8. Ceva Sante Animale
14.8.1. Company details
14.8.2. Financial outlook
14.8.3. Product summary
14.8.4. Recent developments
14.9. Dechra Pharmaceuticals PLC
14.9.1. Company details
14.9.2. Financial outlook
14.9.3. Product summary
14.9.4. Recent developments
14.10. General Mills (Blue Buffalo Pet Products)
14.10.1. Company details
14.10.2. Financial outlook
14.10.3. Product summary
14.10.4. Recent developments
14.11. Others
15. Conclusion
16. List of Abbreviations
17. Reference Links

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us